Deep Genomics
Revolutions in AI, RNA biology, and automation are enabling a new approach to drug development. Deep Genomics is at the forefront.
Description
Revolutions in AI, RNA biology, and automation are enabling a new approach to drug development. Deep Genomics is at the forefront.
Deep Genomics aims to create medicine in a similar way we code computer programs.
The company is focusing on the development of steric-blocking oligonucleotides (SBOs) that target the genetic determinants of disease at the level of RNA or DNA. These genetic diseases are mediated by altered molecular phenotypes, such as transcription, splicing, translation, and protein binding. Predicting those alterations is our core competency. The oligonucleotide therapeutic design space includes tens of billions of compounds, but Deep Genomic’s platform makes it possible to search this space efficiently.
Reviews
There are no reviews yet.